Cargando…

Identification of Biomarkers for Osteosarcoma Based on Integration Strategy

BACKGROUND: Osteosarcoma (OS) is the most common primary malignant tumor of bone. The identification of novel biomarkers is necessary for the diagnosis and treatment of osteosarcoma. MATERIAL/METHODS: We obtained 11 paired fresh-frozen OS samples and normal controls from patients between September 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Junjie, Song, Zhaona, Song, Chunyu, Wang, Yahui, Li, Wan, Mai, Wei, Shi, Qingyu, Yu, Hongwei, Ni, Linying, Liu, Yishu, Lu, Xiaolin, He, Chuan, Chen, Lina, Qu, Guofan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101204/ https://www.ncbi.nlm.nih.gov/pubmed/32173717 http://dx.doi.org/10.12659/MSM.920803

Ejemplares similares

A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse
por: Bao, Junjie, et al.
Publicado: (2019)

Glycogen synthase kinase 3β promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase
por: Mai, Wei, et al.
Publicado: (2021)

Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
por: He, Chuan, et al.
Publicado: (2022)

The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients
por: Yu, Hongwei, et al.
Publicado: (2019)

A susceptibility biomarker identification strategy based on significantly differentially expressed ceRNA triplets for ischemic cardiomyopathy
por: Zou, Yuqing, et al.
Publicado: (2020)

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
por: Li, Kexin, et al.
Publicado: (2023)

Integration of SNP Disease Association, eQTL, and Enrichment Analyses to Identify Risk SNPs and Susceptibility Genes in Chronic Obstructive Pulmonary Disease
por: Liu, Yang, et al.
Publicado: (2020)

The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis
por: Bao, Junjie, et al.
Publicado: (2016)

Association of high PDPN expression with pulmonary metastasis of osteosarcoma and patient prognosis
por: Wang, Xincheng, et al.
Publicado: (2019)

Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7
por: Xue, Zhen, et al.
Publicado: (2015)

REG γ knockdown suppresses proliferation by inducing apoptosis and cell cycle arrest in osteosarcoma
por: Yin, Zhiqiang, et al.
Publicado: (2020)

A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma
por: Zhang, Lina, et al.
Publicado: (2022)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)

Molecular pathogenesis and therapeutic strategies of human osteosarcoma
por: Denduluri, Sahitya K, et al.
Publicado: (2016)

An integrative multi-platform analysis for discovering biomarkers of osteosarcoma
por: Li, Guodong, et al.
Publicado: (2009)

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
por: Wang, Xinxing, et al.
Publicado: (2022)

Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes
por: Guo, Junjie, et al.
Publicado: (2021)

miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma
por: He, Chuan, et al.
Publicado: (2020)

PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma
por: Jiang, Haoli, et al.
Publicado: (2020)

Immunotherapeutic Strategies in the Management of Osteosarcoma
por: Supra, Rajiv, et al.
Publicado: (2023)

Krüppel‐like factor 4 promotes high‐mobility group box 1‐induced chemotherapy resistance in osteosarcoma cells
por: Huang, Jun, et al.
Publicado: (2016)

Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
por: Suehara, Yoshiyuki, et al.
Publicado: (2012)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma
por: Wang, Jun, et al.
Publicado: (2021)

Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms
por: Li, Guibin, et al.
Publicado: (2023)

The regulatory effect of has-circ-0001146/miR-26a-5p/MNAT1 network on the proliferation and invasion of osteosarcoma
por: Wang, Junjie, et al.
Publicado: (2020)

Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)

Special Issue “Osteosarcomas: Treatment Strategies”
por: Park, See-Hyoung
Publicado: (2023)

Identification and analysis of key genes in osteosarcoma using bioinformatics
por: Diao, Chunyu, et al.
Publicado: (2018)

Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis
por: Luo, Huan, et al.
Publicado: (2020)

Potential Regulatory Effects of miR-182-3p in Osteosarcoma via Targeting EBF2
por: Chen, Gaoyang, et al.
Publicado: (2019)

Regulation of Intrinsic and Extrinsic Apoptotic Pathways in Osteosarcoma Cells Following Oleandrin Treatment
por: Ma, Yunlong, et al.
Publicado: (2016)

Research status and progress of the RNA or protein biomarkers for prostate cancer
por: Song, Chunjiao, et al.
Publicado: (2019)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021)

Identification of LTF as a Prognostic Biomarker for Osteosarcoma
por: Liu, Xiaoqi, et al.
Publicado: (2022)

Non-coding RNAs as potential biomarkers in osteosarcoma
por: Fan, Lijuan, et al.
Publicado: (2022)

Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma
por: Wu, Hongliang, et al.
Publicado: (2023)

Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis
por: Wang, Da-wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o1l3dkspnebaj854jabhjr6u6l